{"url_path":"/sec/si/8-k/2026-04-27/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1699350/0001699350-26-000021-index.html","accession_number":"0001699350-26-000021","cik":"0001699350","ticker":"SI","issuer_name":"SHOULDER INNOVATIONS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1699350/0001699350-26-000021-index.html","primary_entity_key":"0001699350","primary_entity_name":"SHOULDER INNOVATIONS, INC."},"word_count":133,"has_tables":true,"body_markdown":"Item 7.01.\nRegulation FD Disclosure.\n\nOn April 27, 2026, Shoulder Innovations, Inc. (the “Company”) issued a press release announcing the full commercial launch of the InSet™ I-135RFX Humeral Stem. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.\n\nThe information contained in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing."}